Issues and Uncertainties in Estimating the Health Benefits of Air Pollution Control

The estimation of health benefits from reductions in ambient air pollution requires information both about the relationship between concentrations and health effects and about the ultimate value of health outcomes. In this commentary, I discuss significant issues and uncertainties that must be addressed for both elements. Critical issues for concentration-response estimation include the shape of the concentration-response curve at current and projected ambient levels, the relevant exposure period, the existence of high-risk subpopulations, and the ability to generalize across study settings. Health outcomes can be valued using either health-based measures like quality-adjusted life years or economic measures like value of statistical life; the choice of measure has a significant effect on the magnitude and distribution of health benefits. Analysts estimating health benefits for ultimate benefit-cost applications should provide results using multiple valuation frameworks and multiple assumptions about health evidence to facilitate interpretation and to determine whether policy decisions depend on these assumptions.

[1]  T. Lefèvre,et al.  Assessing Health Benefits of Controlling Air Pollution from Power Generation: The Case of a Lignite-Fired Power Plant in Thailand , 2001, Environmental management.

[2]  R. Revesz,et al.  Environmental regulation, cost-benefit analysis, and the discounting of human lives. , 1999, Columbia law review.

[3]  D. Dockery,et al.  Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. , 1995, American journal of respiratory and critical care medicine.

[4]  James K. Hammitt,et al.  Valuing Mortality Risk: Theory and Practice† , 2000 .

[5]  J. Vandenberg,et al.  Research priorities: airborne particulate matter , 2001 .

[6]  Jonathan I Levy,et al.  The importance of population susceptibility for air pollution risk assessment: a case study of power plants near Washington, DC. , 2002, Environmental health perspectives.

[7]  R. Burnett,et al.  Impact of Particulate Air Pollution on Quality-Adjusted Life Expectancy in Canada , 2003, Journal of toxicology and environmental health. Part A.

[8]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[9]  R. Burnett,et al.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. , 2002, JAMA.

[10]  S L Zeger,et al.  Estimating particulate matter-mortality dose-response curves and threshold levels: an analysis of daily time-series for the 20 largest US cities. , 2000, American journal of epidemiology.